Skip to main content

Table 1 Effects of compounds on VDRs

From: Functional evolution of the vitamin D and pregnane X receptors

Common name

Significance

Human VDR

EC50 ± SD

(relative efficacy)

Mouse VDR

EC50 ± SD

(relative efficacy)

Xenopus VDR

EC50 ± SD

(relative efficacy)

Zebrafish VDR

EC50 ± SD

(relative efficacy)

Sea lamprey VDR

EC50 ± SD

(relative efficacy)

Ciona VDR/PXR

EC50 ± SD

(relative efficacy)

1,25-(OH)2-Vitamin D3

Vitamin D

1.2 ± 0.2 nM (1.0a)

0.6 ± 0.1 nM (1.0a)

33 ± 3.5 nM (1.0a)

0.7 ± 0.1 nM (1.0a)

0.8 ± 0.1 nM (1.0a)

No effect

1α-Hydroxyvitamin D2

ligands

13 ± 1.2 nM (0.88)

0.8 ± 0.1 nM (0.98)

624 ± 49 nM (0.58)

26 ± 1.7 nM (0.78)

41 ± 3.6 nM (0.88)

No effect

1α-Hydroxyvitamin D3

 

4.3 ± 0.5 nM (0.99)

0.3 ± 0.04 nM (0.96)

157 ± 10 nM (0.84)

18 ± 1.4 nM (0.73)

94 ± 8.0 nM (0.90)

No effect

25-Hydroxyvitamin D3

 

1.5 ± 0.2 M (1.22)

0.6 ± 0.1 μM (2.62)

11 ± 0.8 nM (0.67)

7.3 ± 0.8 μM (0.91)

19 ± 2.1 μM (0.63)

No effect

24(R),25-(OH)2-Vitamin D3

 

0.3 ± 0.02 μM (0.9)

0.3 ± 0.02 μM (1.7)

11 ± 1.7 μM (0.20)

0.7 ± 0.06 μM (0.6)

5.6 ± 0.8 μM (0.9)

No effect

5α-Petromyzonol

Bile salts from

No effect

No effect

No effect

No effect

No effect

No effect

5α-Petromyzonol 24-sulfate

sea lamprey

No effect

No effect

No effect

No effect

No effect

No effect

5α-Cyprinol

Major bile salt

No effect

No effect

No effect

No effect

No effect

No effect

5α-Cyprinol 27-sulfate

for zebrafish and Xenopus species

No effect

No effect

No effect

No effect

No effect

No effect

Lithocholic acid

Major human

11 ± 0.7 (0.12)

7.1 ± 0.9 (0.36)

No effect

No effect

No effect

No effect

Glycolithocholic acid

secondary

No effect

16 ± 2.1 (0.28)

No effect

No effect

No effect

No effect

Taurolithocholic acid

bile acids and

No effect

26 ± 3.8 (0.23)

No effect

No effect

No effect

No effect

Lithocholic acid 3-sulfate

metabolities

No effect

No effect

No effect

No effect

No effect

No effect

3-Ketolithocholic acid

 

55 ± 8.1 (0.17)

20 ± 0.3 (0.58)

No effect

No effect

No effect

No effect

6-Formylindolo- [3,2-b]-carbazole

Miscellaneous

> 10 (~0.12)

> 10 (~0.08)

> 10 (~0.10)

~5 (< 0.03)

2.0 ± 0.3 (0.25)

0.86 ± 0.081 (1.0a)

2,3,7,8-Tetrachlorodibenzo-p-dioxin

 

No effect

No effect

No effect

No effect

No effect

0.23 ± 0.04 (1.80)

  1. a Maximal reference compound (efficacy = 1.0) ; efficacy of other compounds are relative to the maximal reference compound.